Published in J Am Soc Nephrol on November 29, 2010
Genomics of Chronic Renal Allograft Rejection (The GoCAR Study) | NCT00611702
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition. J Am Soc Nephrol (2012) 2.26
Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46
Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens (2012) 1.46
Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol (2011) 1.26
Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease. BMC Nephrol (2012) 1.16
NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury. J Am Soc Nephrol (2012) 1.10
Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology. PLoS One (2013) 1.02
Automated quantification of renal fibrosis with Sirius Red and polarization contrast microscopy. Physiol Rep (2014) 0.97
Severe renal mass reduction impairs recovery and promotes fibrosis after AKI. J Am Soc Nephrol (2014) 0.93
What is the best way to measure renal fibrosis?: A pathologist's perspective. Kidney Int Suppl (2011) (2014) 0.90
Profiling of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small cell lung cancer. J Histochem Cytochem (2014) 0.90
Epithelial cells as active player in fibrosis: findings from an in vitro model. PLoS One (2013) 0.89
Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis. Toxicol Lett (2013) 0.88
Quantification of myocardial fibrosis by digital image analysis and interactive stereology. Diagn Pathol (2014) 0.87
Shear wave elastography in chronic kidney disease: a pilot experience in native kidneys. BMC Nephrol (2015) 0.87
The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions. J Am Soc Nephrol (2015) 0.83
Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction. Stem Cell Res Ther (2015) 0.83
Urinary retinol binding protein is a marker of the extent of interstitial kidney fibrosis. PLoS One (2014) 0.81
High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy. PLoS One (2014) 0.80
The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction. Am J Physiol Renal Physiol (2016) 0.80
Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD. J Am Soc Nephrol (2015) 0.80
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. J Transl Med (2014) 0.80
Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney Int (2013) 0.79
Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol (2011) 0.79
Effect of prenatal programming and postnatal rearing on glomerular filtration rate in adult rats. Am J Physiol Renal Physiol (2014) 0.78
Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2. Am J Physiol Renal Physiol (2014) 0.77
Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis. J Am Soc Nephrol (2016) 0.77
Navigating the challenges of fibrosis assessment: land in sight? J Am Soc Nephrol (2010) 0.77
Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique. J Am Soc Nephrol (2015) 0.77
New Magnetic Resonance Imaging Index for Renal Fibrosis Assessment: A Comparison between Diffusion-Weighted Imaging and T1 Mapping with Histological Validation. Sci Rep (2016) 0.76
Epigallocatechin-3-gallate attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis in mice. J Histochem Cytochem (2014) 0.76
CD4 T cell knockout does not protect against kidney injury and worsens cancer. J Mol Med (Berl) (2015) 0.76
Transient enalapril attenuates the reduction in glomerular filtration rate in prenatally programmed rats. Physiol Rep (2017) 0.75
Renal Medullary and Cortical Correlates in Fibrosis, Epithelial Mass, Microvascularity, and Microanatomy Using Whole Slide Image Analysis Morphometry. PLoS One (2016) 0.75
Image Analysis or Stereology: Which to Choose for Quantifying Fibrosis? J Histochem Cytochem (2015) 0.75
Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor. Sci Rep (2016) 0.75
Prevalence of amyloid deposition in mature healthy chickens in the flock that previously had outbreaks of vaccine-associated amyloidosis. J Vet Med Sci (2015) 0.75
Prophylactic orthosteric inhibition of leukocyte integrin CD11b/CD18 prevents long-term fibrotic kidney failure in cynomolgus monkeys. Nat Commun (2017) 0.75
Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis. J Am Soc Nephrol (2016) 0.75
Noninvasive Assessment of Renal Fibrosis with Magnetization Transfer MR Imaging: Validation and Evaluation in Murine Renal Artery Stenosis. Radiology (2016) 0.75
Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model. PLoS One (2016) 0.75
Increased risk of renal biopsy complications in patients with IgA-nephritis. Clin Exp Nephrol (2015) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J (1979) 8.95
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int (2009) 7.45
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int (2009) 7.19
Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol (2004) 6.75
Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol (2008) 5.83
Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int (2006) 4.87
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet (1968) 2.58
Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol (2009) 2.12
Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant (2005) 1.79
The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol (2008) 1.66
Quantitation of allograft fibrosis and chronic allograft nephropathy. Pediatr Transplant (1999) 1.60
International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. Kidney Int (2001) 1.59
Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol (2001) 1.46
Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol (2003) 1.45
Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci (2008) 1.44
Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation (1994) 1.39
Treatment targets in renal fibrosis. Nephrol Dial Transplant (2007) 1.19
Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int (2007) 1.17
Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant (2004) 1.10
The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol (2003) 1.09
Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis. Nephrol Dial Transplant (2004) 1.05
Emerging therapies for chronic kidney disease: what is their role? Nat Rev Nephrol (2009) 1.03
Hepatocyte growth factor: new arsenal in the fights against renal fibrosis? Kidney Int (2006) 1.02
Quantification of interstitial fibrosis by image analysis on routine renal biopsy in patients receiving cyclosporine. Transplantation (2007) 1.02
Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis. Kidney Int (2008) 1.01
Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant (2005) 0.99
Reproducibility of the Banff classification of renal allograft pathology. Inter- and intraobserver variation. Transplantation (1995) 0.97
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus. Am J Transplant (2009) 0.97
Morphometry of interstitial fibrosis. Nephrol Dial Transplant (2000) 0.95
Fibrosis and atrophy in the renal allograft: interim report and new directions. Am J Transplant (2002) 0.89
Enhanced expression of renal endothelin-converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation. J Cardiovasc Pharmacol (2000) 0.89
Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant (2001) 0.87
Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejection. Transplantation (1999) 0.86
eGFR: Readjusting its rating. Clin J Am Soc Nephrol (2009) 0.85
Quantification of interstitial chronic renal damage by means of texture analysis. Kidney Int (1994) 0.80
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med (2003) 4.20
Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83
Case records of the Massachusetts General Hospital. Case 31-2007. A 41-year-old man with abdominal pain and elevated serum creatinine. N Engl J Med (2007) 2.71
Case records of the Massachusetts General Hospital. Case 23-2010. A 49-year-old man with erythrocytosis, perinephric fluid collections, and renal failure. N Engl J Med (2010) 2.62
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol (2009) 2.15
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int (2002) 2.15
Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med (2003) 2.15
Pros and cons for C4d as a biomarker. Kidney Int (2012) 2.03
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Antibody-mediated organ-allograft rejection. Nat Rev Immunol (2005) 1.99
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97
Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A (2009) 1.95
Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol (2011) 1.92
Diffusion tensor MRI of myocardial fibers and sheets: correspondence with visible cut-face texture. J Magn Reson Imaging (2003) 1.88
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 1.82
Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol (2005) 1.79
A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. J Am Soc Nephrol (2006) 1.77
Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int (2011) 1.73
Case records of the Massachusetts General Hospital. Case 17-2005. A 22-year-old woman with back and leg pain and respiratory failure. N Engl J Med (2005) 1.72
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72
Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol (2009) 1.70
Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation. Pediatr Nephrol (2013) 1.66
Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol (2006) 1.62
NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol (2005) 1.58
Case records of the Massachusetts General Hospital. Case 28-2005. A 42-year-old man with weight loss, weakness, and a rash. N Engl J Med (2005) 1.55
Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol (2007) 1.53
Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol (2006) 1.50
IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol (2002) 1.48
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2003. A 68-year-old woman with impaired renal function. N Engl J Med (2003) 1.47
Xenogeneic thymus transplantation in a pig-to-baboon model. Transplantation (2003) 1.47
Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46
Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens (2012) 1.46
Kidney transplantation: mechanisms of rejection and acceptance. Annu Rev Pathol (2008) 1.46
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 21-2003. A 72-year-old man with repetitive strokes in the posterior circulation. N Engl J Med (2003) 1.45
Pathology after eculizumab in dense deposit disease and C3 GN. J Am Soc Nephrol (2012) 1.43
A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial of Aminophylline to Prevent Acute Kidney Injury in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass. Pediatr Crit Care Med (2016) 1.40
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2002. A 17-year-old boy with acute mitral regurgitation and pulmonary edema. N Engl J Med (2002) 1.39
Penis Transplantation: First US Experience. Ann Surg (2017) 1.38
Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol (2008) 1.36
Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J (2004) 1.28
Early acceptance of renal allografts in mice is dependent on foxp3(+) cells. Am J Pathol (2011) 1.23
Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Am J Respir Cell Mol Biol (2005) 1.18
Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney Int (2009) 1.18
Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol (2008) 1.11
Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol (2008) 1.11
Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol (2009) 1.10
Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation (2010) 1.10
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation (2002) 1.10
Humoral rejection of human organ transplants. Springer Semin Immunopathol (2003) 1.10
Chronic allograft nephropathy. Curr Opin Nephrol Hypertens (2005) 1.09
Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J Immunol (2008) 1.07
Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol (2009) 1.05
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice. Clin Immunol (2007) 1.04
The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes (2002) 1.04
Dense IgG4 plasma cell infiltrates associated with chronic infectious aortitis: implications for the diagnosis of IgG4-related disease. Cardiovasc Pathol (2012) 1.03
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation (2006) 1.03
Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens (2002) 1.02
Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes (2002) 1.00
Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness. Transplantation (2003) 1.00
GalT-KO pigs: is the cup half empty or half full? Transplantation (2007) 0.99
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with amyloid deposition: a clinicopathologic case series. Am J Clin Pathol (2012) 0.97
Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am J Transplant (2003) 0.96
Biomarkers and surrogate endpoints in renal transplantation: present status and considerations for clinical trial design. Am J Transplant (2004) 0.95
Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition. J Biol Chem (2010) 0.94
Case records of the Massachusetts General Hospital. Case 12-2007. A 56-year-old woman with renal failure after heart-lung transplantation. N Engl J Med (2007) 0.93
C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant (2005) 0.92
Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes (2004) 0.92
Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients. Transplantation (2012) 0.92
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts. Transplantation (2011) 0.91
Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation (2006) 0.91
Role of complement and NK cells in antibody mediated rejection. Hum Immunol (2012) 0.89
Pathologic characteristics of transplanted kidney xenografts. J Am Soc Nephrol (2011) 0.89
Diagnostic challenges in chronic antibody-mediated rejection. Nat Rev Nephrol (2012) 0.88
Chronic alloantibody mediated rejection. Semin Immunol (2011) 0.87
A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation. Ann Surg (2016) 0.87
Divergent role of donor dendritic cells in rejection versus tolerance of allografts. J Am Soc Nephrol (2009) 0.87
Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation (2002) 0.87
Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons. Xenotransplantation (2012) 0.87
Effect of T cells on vascular permeability in early ischemic acute kidney injury in mice. Microvasc Res (2009) 0.86
Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function. Transplantation (2003) 0.85
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis. Kidney Int (2002) 0.85
Pathological features of antibody-mediated rejection. Curr Drug Targets Cardiovasc Haematol Disord (2005) 0.85
Initial experience using aminophylline to improve renal dysfunction in the pediatric cardiovascular ICU. Pediatr Crit Care Med (2014) 0.84